Tower Research Capital (TRC)’s 60 Degrees Pharmaceuticals SXTP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.16K | Buy |
2,598
+1,048
| +68% | +$2.48K | ﹤0.01% | 4126 |
|
2025
Q1 | $2.85K | Buy |
1,550
+804
| +108% | +$1.48K | ﹤0.01% | 4494 |
|
2024
Q4 | $4.81K | Buy |
746
+451
| +153% | +$2.91K | ﹤0.01% | 4395 |
|
2024
Q3 | $1.84K | Buy |
295
+177
| +150% | +$1.11K | ﹤0.01% | 5096 |
|
2024
Q2 | $1.8K | Buy |
118
+3
| +3% | +$46 | ﹤0.01% | 5090 |
|
2024
Q1 | $1.81K | Buy |
115
+64
| +125% | +$1.01K | ﹤0.01% | 5180 |
|
2023
Q4 | $3.14K | Buy |
51
+1
| +2% | +$62 | ﹤0.01% | 5122 |
|
2023
Q3 | $2.22K | Buy |
+50
| New | +$2.22K | ﹤0.01% | 5195 |
|